What is CNTN's treasury stock, shares (in shares)?

CNTN (CNTN) reported treasury stock, shares (in shares) of $246 in Q1 2026.

How has CNTN's treasury stock, shares (in shares) changed year-over-year?

CNTN's treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $246 to $246.

Over 3 years (2022 to 2025), CNTN's treasury stock, shares (in shares) has grown at a -59.2% compound annual growth rate (CAGR), from $3.63K to $246.

AbbVieABBV

——

Operating income-$36.9M-1,348%

Net income-$47.3M-1,763%

EPS (diluted)-$0.23+76.8%

Cash & equivalents$41.5M+3,760%

Total debt$1.4M0.0%

Total equity$469.8M+57,767%

Total assets$584.7M+35,093%

Operating cash flow-$7.6M-184%

Market cap$217.49M+8.0%

Return on equity-18%-8.6pp

Debt / equity0.3×—

Current ratio37.7×+37.1×

Reported directly by CNTN in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: CNTN’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is CNTN's treasury stock, shares (in shares)?: CNTN (CNTN) reported treasury stock, shares (in shares) of $246 in Q1 2026.
How has CNTN's treasury stock, shares (in shares) changed year-over-year?: CNTN's treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $246 to $246.
What is the long-term trend for CNTN's treasury stock, shares (in shares)?: Over 3 years (2022 to 2025), CNTN's treasury stock, shares (in shares) has grown at a -59.2% compound annual growth rate (CAGR), from $3.63K to $246.